ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth,...

a adăugat un sunet Hogar

2026-04-07 12:37:48 - Translate

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Report Focuses on Top Companies Analysis By FMI

NEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...

0 Commentarii 0 Distribuiri 6 Views 0 previzualizare